A federal judge in the Northern District of Texas, Reed O’Connor, issued an order on Sunday delaying a legal challenge that seeks to revoke the Food and Drug Administration’s (FDA) long-standing approval of mifepristone, a pill commonly used for medication abortion. The pause was granted in response to a motion filed by the Department of Justice, which requested more time to address the case.

The lawsuit, which aims to overturn federal authorization of the drug, has become a focal point in the ongoing national debate over reproductive rights. By pushing the proceedings past the midterm elections, the court has effectively removed the immediate legal developments of this case from the current election cycle. While the court has granted the delay, the core legal arguments regarding the FDA's regulatory authority over the drug remain pending. The Department of Justice has not yet provided a detailed public timeline for its next steps once the stay is lifted, but the move ensures that the litigation will not reach a critical juncture while voters are heading to the polls.